HCP (HCP) : The consensus on HCP (HCP) based on 10 analyst recommendation on the company stock is 3.53, which is interpreted as a Sell recommendation. Zacks Investment Research has issued a rank of 2 which endorses a Buy on the stock. However, 1 analyst believes that the stock is a Buy, which can produce decent returns in the future. 5 experts consider that the stocks earnings and the quoted price is in harmony, hence, they give it a Hold rating. 3 analyst sees the stock overvalued at current levels and advises a Strong Sell on the stock. 1 analyst also believes that the downside risk to the stock is higher and suggests a Sell on HCP (HCP).
HCP (HCP) : The consensus price target for HCP (HCP) is $35.57 for the short term with a standard deviation of $3.99. The most optimist securities analyst among the 7 who monitor the stock believes that the stock can reach $43, however, the pessimist price target for the company is $32.
Also, BTIG Research initiates coverage on HCP (NYSE:HCP). The shares have now been rated Neutral by the stock experts at the ratings house. The rating by the firm was issued on August 25, 2016.
HCP (NYSE:HCP): After opening at $36.89, the stock dipped to an intraday low of $36.65 on Thursday. However, the bulls stepped in to buy at lower levels and pushed the stock higher. The stock touched an intraday high of $37.21 and the buying power remained strong till the end. The stock closed at $37.03 for the day, a gain of 0.24% for the day session. The total traded volume was 2,387,086. The stocks close on the previous trading day was $36.94.
HCP, Inc. (HCP) is a real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing, post-acute/skilled nursing, life science, medical office and hospital. Its portfolio includes owned portfolio, unconsolidated joint ventures, and developments and redevelopments. Its owned portfolio includes around 1,040 properties under lease and 68 operating properties. It has interests in unconsolidated joint ventures representing around 88 properties in its senior housing, life science and medical office segments. It has assets under development, redevelopment and land held for future development in life science and medical office segments. The properties owned by it in medical office and senior housing segments, which are under development or redevelopment include Pacific Corporate Park, Memorial Hermann, Sky Ridge, Bayfront, Folsom and Deer Park.